GLP-1 receptors are found in the brain, and GLP-1 signaling may influence appetite, glucose regulation, inflammation, vascular function, and possibly neuronal stress pathways
People who discuss microdosing often describe feeling more involved in dose adjustments, especially when tolerance, lifestyle, or GLP-1 accessibility concerns come into play
Some of that can be reasonable
The appetite-suppressing effects could be beneficial for some individuals struggling with binge eating disorder, helping to regulate food intake
Patient stories and the human side Clinical practice is full of examples that illustrate both the promise and the complexity of these tools
Micro-dosing involves using smaller-than-standard doses of GLP-1 medications like Ozempic or Mounjaro